Evidence map›Paper›PMID 39975937›Full record

ArticleChina CDC weekly2025

Advances in HPV-Associated Cervical Cancer Dynamic Modelling for Prevention and Control Evaluation.

Yuxi He, Han Ni, Wentao Kuang, Liuyi Fu, Shanghui Yi, Wenting Zha, Yuan Lyu

Abstract read
In one paragraph

Article in China CDC weekly, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yuxi HeHunan Key Laboratory of Molecular Epidemiology, School of Medicine, Hunan Normal University, Changsha City, Hunan Province, China.
Han NiHunan Key Laboratory of Molecular Epidemiology, School of Medicine, Hunan Normal University, Changsha City, Hunan Province, China.
Wentao KuangHunan Key Laboratory of Molecular Epidemiology, School of Medicine, Hunan Normal University, Changsha City, Hunan Province, China.
Liuyi FuHunan Key Laboratory of Molecular Epidemiology, School of Medicine, Hunan Normal University, Changsha City, Hunan Province, China.
Shanghui YiHunan Key Laboratory of Molecular Epidemiology, School of Medicine, Hunan Normal University, Changsha City, Hunan Province, China.
Wenting ZhaHunan Key Laboratory of Molecular Epidemiology, School of Medicine, Hunan Normal University, Changsha City, Hunan Province, China.
Yuan LyuHunan Key Laboratory of Molecular Epidemiology, School of Medicine, Hunan Normal University, Changsha City, Hunan Province, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cervical cancer is a common malignancy in women, with persistent human papillomavirus (HPV) infection as its primary cause. Understanding the progression from HPV infection to cervical cancer is crucial. Mathematical models play a key role in converting clinical trial data into long-term health forecasts, helping decision-makers tackle challenges posed by limited data and uncertain outcomes. This paper reviews transmission dynamics models and advancements in simulating HPV transmission leading to cervical cancer. It evaluates preventive and control measures, focusing on the impact of HPV vaccination across different vaccine types, doses, age groups, and both genders. These model-based assessments aim to provide insights for developing effective strategies to prevent and control HPV-related cervical cancer.

Indexed as

Cervical cancerHuman papillomavirusPrevention efficacy evaluationTransmission dynamics models

Identifiers

PMID39975937
PMCPMC11832444

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.